Hemorrhagic Myocardial Infarction Detection by Post-reperfusion Troponin Kinetics
Completed
Conditions studied: Acute Myocardial Infarction
In brief
Pilot trial to determine diagnostic efficacy of post-reperfusion troponin kinetics in detection of hemorrhagic myocardial infarction
Key facts
- Study ID
- NCT05872308
- Run by
- Rohan Dharmakumar
- People needed
- 227
- Starts
- 2022-07-08
- Expected to finish
- 2025-01-21
- Last updated by the study team
- 2025-09-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Index STEMI
- Coronary angiogram with PCI to occur irrespective of the onset of the symptoms.
- Ability to provide informed consent for themselves
You may not qualify if…
- History of prior myocardial infarction,
- Cardiogenic shock,
- Patients who present with current cardiac arrest
- Any contraindication to cardiac CMR (claustrophobia, pacemaker or cardiac defibrillator, known allergy to gadolinium),
- Presence of permanent atrial fibrillation,
- Unconscious patient,
- Severe renal insufficiency (creatinine clearance ≤ 30 ml/min/m2 or renal replacement therapy),
- Women who are pregnant or breastfeeding. Women of reproductive potential must have a negative pregnancy test.
Where it is running
- IU Methodist Hospital — Indianapolis, Indiana, United States
- Synergy Cardiovascular Research Center, Synergy Superspecialty Hospital — Rajkot, Gujarat, India
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.